HH
MRNA icon

Hilltop Holdings’s Moderna MRNA Stock Holding History

Hilltop Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,418
Closed -$218K – 593
2023
Q1 		$218K Sell
1,418
-89
-6% -$14.7K 0.03% 485
2022
Q4 		$271K Buy
+1,507
New +$246K 0.03% 412
2022
Q3 		– Sell
-1,604
Closed -$229K – 540
2022
Q2 		$229K Buy
1,604
+156
+11% +$22.3K 0.03% 446
2022
Q1 		$250K Sell
1,448
-2,176
-60% -$366K 0.03% 480
2021
Q4 		$921K Sell
3,624
-759
-17% -$222K 0.1% 198
2021
Q3 		$1.69M Buy
4,383
+918
+26% +$339K 0.18% 113
2021
Q2 		$814K Sell
3,465
-423
-11% -$75.6K 0.09% 211
2021
Q1 		$509K Sell
3,888
-1,421
-27% -$206K 0.07% 288
2020
Q4 		$555K Buy
5,309
+532
+11% +$53.8K 0.08% 242
2020
Q3 		$338K Buy
4,777
+1,117
+31% +$77.9K 0.06% 297
2020
Q2 		$235K Sell
3,660
-16,896
-82% -$925K 0.04% 339
2020
Q1 		$616K Buy
+20,556
New +$473K 0.15% 157

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hilltop Holdings's MRNA Position: Q2 2023 in Review

Hilltop Holdings sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,418 shares — an estimated $218K sold.

Hilltop Holdings first reported a position in MRNA in Q1 2020 and held it in 12 quarters. The position peaked at $1.69M in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Hilltop Holdings reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Hilltop Holdings sold 1,418 Moderna shares in Q2 2023, an estimated $218K.
  • Hilltop Holdings first reported a position in Moderna in Q1 2020 and held it in 12 quarters.
  • Hilltop Holdings's Moderna position peaked at $1.69M in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Hilltop Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.